Human Cardiac Gene Therapy
- PMID: 30355138
- PMCID: PMC6390977
- DOI: 10.1161/CIRCRESAHA.118.311587
Human Cardiac Gene Therapy
Abstract
In the past 10 years, there has been tremendous progress made in the field of gene therapy. Effective treatments of Leber congenital amaurosis, hemophilia, and spinal muscular atrophy have been largely based on the efficiency and safety of adeno-associated vectors. Myocardial gene therapy has been tested in patients with heart failure using adeno-associated vectors with no safety concerns but lacking clinical improvements. Cardiac gene therapy is adapting to the new developments in vectors, delivery systems, targets, and clinical end points and is poised for success in the near future.
Keywords: AAV; Clinical trial; Leber congenital amaurosis; gene therapy; heart failure; myocardium.
Figures
References
-
- Mendel G Versuche über Pflanzen-Hybriden. Brünn :: Im Verlage des Vereines; 1866.
-
- Mendel G and Bateson W. Experiments in plant-hybridisation. Cambridge, Mass: :: Harvard University Press; 1925.
-
- Watson JD and Crick FH. Molecular structure of nucleic acids; a structure for deoxyribose nucleic acid. Nature. 1953;171:737–8. - PubMed
-
- Nirenberg M and Leder P. Rna Codewords and Protein Synthesis. The Effect of Trinucleotides Upon the Binding of Srna to Ribosomes. Science. 1964;145:1399–407. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous